Marijuana as a Substitute for Prescription Medications: A Qualitative Study

References

• Abrams, D. I., Couey, P., Shade, S. B., Kelly, M. E., & Benowitz, N. L. (2011). Cannabinoid-opioid interaction in chronic pain. Clinical Pharmacology & Therapeutics, 90(6), 844–851. doi: 10.1038/clpt.2011.188
   PubMed Web of Science ®Google Scholar
• Aston, E. R., Farris, S. G., Metrik, J., & Rosen, R. K. (2019). Vaporization of marijuana among recreational users: A qualitative study. Journal of Studies on Alcohol and Drugs, 80(1), 56–62. doi: 10.15288/jsad.2019.80.56
   PubMed Web of Science ®Google Scholar
• Bachhuber, M. A., Saloner, B., Cunningham, C. O., & Barry, C. L. (2014). Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Internal Medicine, 174(10), 1668–1673. doi: 10.1001/jamainternmed.2014.4005
   PubMed Web of Science ®Google Scholar
• Boehnke, K. F., Litinas, E., & Clauw, D. J. (2016). Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. The Journal of Pain, 17(6), 739–744. doi: 10.1016/j.jpain.2016.03.002
   PubMed Web of Science ®Google Scholar
• Bohnert, A. S. B., Valenstein, M., Bair, M. J., Ganoczy, D., McCarthy, J. F., Ilgen, M. A., & Blow, F. C. (2011). Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA, 305(13), 1315–1321. doi: 10.1001/jama.2011.370
   PubMed Web of Science ®Google Scholar
• Bottorff, J. L., Bissell, L. J., Balneaves, L. G., Oliffe, J. L., Capler, N. R., & Buxton, J. (2013). Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study. Harm Reduction Journal, 10(1), 2. doi: 10.1186/1477-7517-10-2
   PubMedGoogle Scholar
• Bradford, A. C., Bradford, W. D., Abraham, A., & Adams, G. B. (2018). Association between US state medical cannabis laws and opioid prescribing in the medicare part D population. JAMA Internal Medicine, 178(5), 667–672. doi: 10.1001/jamainternmed.2018.0266
   PubMed Web of Science ®Google Scholar
• Bruce, D., Brady, J. P., Foster, E., & Shattell, M. (2018). Preferences for medical marijuana over prescription medications among persons living with chronic conditions: Alternative, complementary, and tapering uses. Journal of Alternative and Complementary Medicine (New York, N.Y.), 24(2), 146–153. doi: 10.1089/acm.2017.0184
   PubMed Web of Science ®Google Scholar
• Coomber, R., Oliver, M., & Morris, C. (2003). Using cannabis therapeutically in the UK: A qualitative analysis. Journal of Drug Issues, 33(2), 325–356. doi: 10.1177/002204260303300204
   Web of Science ®Google Scholar
• Dickson, B., Mansfield, C., Guiahi, M., Allshouse, A. A., Borgelt, L. M., Sheeder, J., … Metz, T. D. (2018). Recommendations from cannabis dispensaries about first-trimester cannabis use. Obstetrics & Gynecology, 131(6), 1031. doi: 10.1097/AOG.0000000000002619
   PubMed Web of Science ®Google Scholar
• Dowell, D., Haegerich, T., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain — United States, 2016. MMWR. Recommendations and Reports, 65(1), 1. doi: 10.15585/mmwr.rr6501e1er
   PubMed Web of Science ®Google Scholar
• Glaser, B. G., & Strauss, A. L. (2017). Discovery of grounded theory: Strategies for qualitative research. London and New York: Routledge.
   Google Scholar
• Goldenberg, M., Reid, M. W., IsHak, W. W., & Danovitch, I. (2017). The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis. Drug and Alcohol Dependence, 174, 80–90. doi: 10.1016/j.drugalcdep.2016.12.030
   PubMed Web of Science ®Google Scholar
• Haug, N. A., Kieschnick, D., Sottile, J. E., Babson, K. A., Vandrey, R., & Bonn-Miller, M. O. (2016). Training and practices of cannabis dispensary staff. Cannabis and Cannabinoid Research, 1(1), 244–251. doi: 10.1089/can.2016.0024
   PubMedGoogle Scholar
• Hill, K. P. (2015). Medical marijuana for treatment of chronic pain and other medical and psychiatric problems. A Clinical Review. JAMA, 313(24), 2474–2483. doi: 10.1001/jama.2015.6199
   PubMed Web of Science ®Google Scholar
• Lau, N., Sales, P., Averill, S., Murphy, F., Sato, S.-O., & Murphy, S. (2015). A safer alternative: Cannabis substitution as harm reduction. Drug and Alcohol Review, 34(6), 654–659. doi: 10.1111/dar.12275
   PubMed Web of Science ®Google Scholar
• Metrik, J., Bassett, S. S., Aston, E. R., Jackson, K. M., & Borsari, B. (2018). Medicinal versus recreational cannabis use among returning veterans. Translational Issues in Psychological Science, 4(1), 6–20. doi: 10.1037/tps0000133
   PubMedGoogle Scholar
• Metrik, J., Rohsenow, D. J., Monti, P. M., McGeary, J., Cook, T. A. R., de Wit, H., … Kahler, C. W. (2009). Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana. Experimental and Clinical Psychopharmacology, 17(4), 217–225. doi: 10.1037/a0016502
   PubMed Web of Science ®Google Scholar
• Nahin, R. L. (2015). Estimates of pain prevalence and severity in adults: United States, 2012. The Journal of Pain: Official Journal of the American Pain Society, 16(8), 769–780. doi: 10.1016/j.jpain.2015.05.002
   PubMed Web of Science ®Google Scholar
• National Academies of Sciences (2017). The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Retrieved from https://www.nap.edu/catalog/24625/the-health-effects-of-cannabis-and-cannabinoids-the-current-state
   Google Scholar
• Page, S. A., & Verhoef, M. J. (2006). Medicinal marijuana use: Experiences of people with multiple sclerosis. Canadian Family Physician Medecin De Famille Canadien, 52, 64–65.
   PubMedGoogle Scholar
• Pedersen, W., & Sandberg, S. (2013). The medicalisation of revolt: A sociological analysis of medical cannabis users. Sociology of Health & Illness, 35(1), 17–32. doi: 10.1111/j.1467-9566.2012.01476.x
   PubMed Web of Science ®Google Scholar
• Peters, D. C. II, (2013). Patients and caregivers report using medical marijuana to decrease prescription narcotics use. Humboldt Journal of Social Relations, 35(1), 24–40.
   Google Scholar
• Reiman, A., Welty, M., & Solomon, P. (2017). Cannabis as a substitute for opioid-based pain medication: Patient self-report. Cannabis and Cannabinoid Research, 2(1), 160–166. doi: 10.1089/can.2017.0012
   PubMedGoogle Scholar
• Rhode Island Department of Health (2008). Rules and regulations related to the medical marijuana program (No. R21-28.6-MMP). Providence, RI: Author.
   Google Scholar
• Rosenblum, A., Marsch, L. A., Joseph, H., & Portenoy, R. K. (2008). Opioids and the treatment of chronic pain: Controversies, current status, and future directions. Experimental and Clinical Psychopharmacology, 16(5), 405–416. doi: 10.1037/a0013628
   PubMed Web of Science ®Google Scholar
• Satterlund, T. D., Lee, J. P., & Moore, R. S. (2015). Stigma among California’s medical marijuana patients. Journal of Psychoactive Drugs, 47(1), 10–17. doi: 10.1080/02791072.2014.991858
   PubMed Web of Science ®Google Scholar
• State Medical Marijuana Laws (2019, March 5). Retrieved April 22, 2019, from http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx
   Google Scholar
• Vandrey, R. (2018). The cannabis conundrum: Steering policy and medicine with insufficient data. International Review of Psychiatry (Abingdon, England), 30(3), 181–182. doi: 10.1080/09540261.2018.1491107
   PubMed Web of Science ®Google Scholar
• Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. B. (2014). Adverse health effects of marijuana use. New England Journal of Medicine, 370(23), 2219–2227. doi: 10.1056/NEJMra1402309
   PubMed Web of Science ®Google Scholar
• Volkow, N. D., & McLellan, A. T. (2016). Opioid abuse in chronic pain—Misconceptions and mitigation strategies. New England Journal of Medicine, 374(13), 1253–1263. doi: 10.1056/NEJMra1507771
   PubMed Web of Science ®Google Scholar
• Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., … Kleijnen, J. (2015). Cannabinoids for medical use: A systematic review and meta-analysis. JAMA, 313(24), 2456–2473. doi: 10.1001/jama.2015.6358
   PubMed Web of Science ®Google Scholar
• Zaller, N., Topletz, A., Frater, S., Yates, G., & Lally, M. (2015). Profiles of medicinal cannabis patients attending compassion centers in Rhode Island. Journal of Psychoactive Drugs, 47(1), 18–23. doi: 10.1080/02791072.2014.999901
   PubMed Web of Science ®Google Scholar